Doxy-PEP: What It Is and Who It Is For

Doxy-PEP, short for doxycycline post-exposure prophylaxis, is a way to reduce the risk of certain bacterial sexually transmitted infections (STIs) after sex. It involves taking doxycycline after sex, before an infection has been diagnosed.

Doxy-PEP is not a general antibiotic to take after any sexual encounter. Current CDC guidance recommends discussing it with certain people who have had a bacterial STI recently, while evidence is still limited for some other groups.

TL;DR: Key takeaways

• Doxy-PEP is doxycycline taken after sex to reduce the risk of some bacterial STIs.
• The CDC recommends discussing doxy-PEP with gay, bisexual, and other men who have sex with men (MSM) and transgender women who had syphilis, chlamydia, or gonorrhea during the previous 12 months.
• The usual dose is 200 mg as soon as possible after sex and within 72 hours, with no more than 200 mg in a 24-hour period.
• Studies have found substantial reductions in chlamydia and syphilis, with a smaller and more variable reduction in gonorrhea.
• Doxy-PEP does not prevent HIV, herpes, or every other STI, so it does not replace condoms, HIV prevention, or regular STI testing.
• Evidence is limited for cisgender women, cisgender heterosexual men, transgender men, and some other populations.
• Regular STI testing remains an important part of care if you use doxy-PEP.

Not sure what to do after a possible STI exposure? Try August AI's free assessment. AI triage can help you figure out what kind of care may be appropriate, but it cannot diagnose an STI or replace STI testing. If you have severe symptoms or an emergency, call 911 or go to the ER. Doxy-PEP evaluation should be handled by a primary care clinician or sexual health provider.

What is doxy-PEP?

Doxy-PEP stands for doxycycline post-exposure prophylaxis. It uses doxycycline, an antibiotic, after sex to lower the chance of developing certain bacterial STIs.

The idea is different from taking antibiotics to treat an infection that has already been diagnosed. With doxy-PEP, the medication is taken after a potential exposure as a preventive measure.

Doxycycline is already used to treat several bacterial infections, including chlamydia. If you are looking for information about treatment after a positive test, see our guide to chlamydia treatment online.

Doxy-PEP is not intended to prevent every STI, and it should not be used as a substitute for testing or appropriate treatment.

Who is doxy-PEP for?

According to the CDC's doxy-PEP guidance, clinicians should discuss doxy-PEP with gay, bisexual, and other MSM and transgender women who have had syphilis, chlamydia, or gonorrhea during the previous 12 months.

The recommendation is based on evidence showing that doxy-PEP can reduce the risk of certain bacterial STIs in these groups.

That does not mean everyone in these groups automatically needs doxy-PEP. A clinician should consider your recent STI history, sexual exposures, other medications, allergies, and overall sexual health before recommending it.

Evidence is still limited for cisgender women, cisgender heterosexual men, transgender men, and some other populations. The CDC does not currently make the same routine recommendation for these groups because the available evidence is not sufficient.

How effective is doxy-PEP?

Clinical studies reviewed by the CDC have found that doxy-PEP can substantially reduce the risk of syphilis and chlamydia among the populations studied. The reduction in gonorrhea has generally been smaller and more variable.

The CDC reports reductions of more than 70% for syphilis and chlamydia in several studies, while protection against gonorrhea has been less consistent. How well doxy-PEP works can also depend on adherence and the population being studied.

Results have not been the same across every population. For example, a randomized trial among cisgender women in Kenya did not find a significant reduction in bacterial STIs. Researchers have suggested that adherence may have contributed to the findings, although other explanations also need to be considered.

That is why it is important not to treat doxy-PEP as a one-size-fits-all STI prevention strategy.

How is doxy-PEP taken?

Under current CDC guidance, the recommended doxy-PEP dose is 200 mg as soon as possible after sex and within 72 hours. The total dose should not exceed 200 mg in a 24-hour period. The CDC provides the current dosing guidance here.

Doxy-PEP may be used after oral, vaginal, or anal sex, depending on the individual's circumstances and the clinician's recommendations.

Doxycycline can cause side effects such as:

• Nausea or stomach upset
• Diarrhea
• Increased sensitivity to sunlight
• Esophageal irritation

Taking doxycycline with food and plenty of water can help reduce stomach and esophageal irritation. Staying upright after taking it can also help reduce the risk of irritation of the esophagus.

Some medicines and supplements can interfere with doxycycline absorption. Antacids and products containing calcium, iron, or magnesium may need to be taken separately from doxycycline. Follow the instructions provided with your prescription or ask your pharmacist about the appropriate timing.

Does doxy-PEP prevent all STIs?

No. Doxy-PEP is primarily used to reduce the risk of certain bacterial STIs.

It has the strongest evidence for reducing syphilis and chlamydia, while protection against gonorrhea is less consistent. It does not prevent viral infections such as HIV or herpes.

If you are at risk for HIV, doxy-PEP is not a substitute for HIV prevention. Depending on your circumstances, HIV PrEP may be an appropriate prevention option.

Doxy-PEP also does not eliminate the need for condoms, vaccination where appropriate, or regular STI screening.

Do you still need STI testing if you take doxy-PEP?

Yes. Doxy-PEP reduces the risk of some bacterial STIs, but it does not guarantee that you will not become infected.

The CDC recommends ongoing STI screening for people using doxy-PEP, with testing generally performed at baseline and every 3 to 6 months. Testing should be performed at the anatomical sites relevant to your sexual exposures.

Regular testing can identify infections that doxy-PEP does not prevent, as well as infections that occur despite prevention.

Learn more about STD testing online and what to expect from an STI screening appointment.

What about antibiotic resistance?

Antibiotic resistance is one of the reasons doxy-PEP needs to be used thoughtfully. Repeated exposure to antibiotics can affect bacteria in the body and may contribute to antibiotic resistance.

Researchers are continuing to study how repeated doxycycline use affects resistance patterns and the microbiome over time. This is one reason clinicians should periodically reassess whether doxy-PEP remains appropriate.

The CDC recommends follow-up and STI screening every 3 to 6 months for people using doxy-PEP. Do not use leftover doxycycline or take someone else's prescription as a substitute for a clinician-guided prevention plan.

Can you get doxy-PEP online?

In some cases, telehealth can be used to discuss whether doxy-PEP is appropriate and, when clinically appropriate and legally permitted, a clinician may prescribe it.

However, not every telehealth service offers doxy-PEP, and not everyone is a candidate for it. A clinician may need to review your recent STI history, sexual exposures, medications, allergies, and other health information before prescribing it.

Depending on your situation, you may also need STI testing or an in-person examination. A telehealth visit does not remove the need for testing when testing is clinically indicated.

Doxy-PEP vs. chlamydia treatment

These are two different uses of doxycycline. Taking doxy-PEP does not mean that a later positive STI test can be ignored or treated without appropriate medical guidance.

When should you talk to a clinician about doxy-PEP?

Consider discussing doxy-PEP with a clinician if:

• You had a bacterial STI during the past year.
• You have had a recent sexual exposure that concerns you.
• A sexual partner has told you they have an STI.
• You have symptoms such as unusual discharge, painful urination, sores, pelvic pain, or testicular pain.
• You want routine STI screening or ongoing prevention.
• You are already taking doxycycline for another reason.
• You are unsure whether doxy-PEP is appropriate for you.

If you have symptoms, do not assume they are caused by an STI or that doxy-PEP will treat them. Testing and clinical evaluation may be necessary.

Conclusion

Doxy-PEP can be a useful STI prevention option for some people, but it is not appropriate for everyone and it does not prevent every STI. The strongest evidence and current CDC recommendation apply to gay, bisexual, and other MSM and transgender women who have had a bacterial STI during the previous 12 months.

Evidence is still developing for other populations. If doxy-PEP is appropriate for you, it should be part of a broader sexual health plan that includes regular STI testing, appropriate HIV prevention, and treatment when an infection is diagnosed.